| Lutz, Phillipe (Telormedix 201005– CFO before Synosia Therapeutics CFO before Credit Suisse) |
Chief Financial Officer (CFO) |
Telormedix S.A. |
Switzerland |
| Lübbert, Hermann (Biofrontera 200311 CEO) |
Chief Executive Officer (CEO) |
Biofrontera (Group) |
Germany |
| Lübke, Julian (Cubuslab 201905 HeadProduct + Co-Founder) |
Product Manager (personnel) |
Labforward (Group) |
Germany |
| Lücke, Klaus (Gilupi GmbH 2006–201605 Managing Director + Founder LEFT 5/16) |
Managing Director |
Viroad (Group) |
Germany |
| Lüdke, Gerd (Curetis 201310 Director Bio-Assay Development) |
Research & Development Manager |
Curetis (Group) |
Germany |
| Lührs, Renke (Buse Heberer Fromm 201508 + DBI AG 201508 Supervisor Board Member) |
Attorney / Lawyer |
Buse Heberer Fromm Rechtsanwälte |
Germany |
| Lührs, Thorsten (SeNostic GmbH 201412– Managing Director + CO-Founder) |
Managing Director |
SeNostic GmbH |
Germany |
| Lüking, Angelika (Protagen 201009 Head R&D) |
Research & Development Manager |
Oncimmune (Group) |
Germany |
| Lynch, Carol (Novartis 201801 Global Head Biopharmaceuticals at Sandoz) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Germany |
| Lynch, John (Waters 201404 VP Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Waters (Group) |
United States (USA) |
| Lynch, Mike (Invoke Capital Founder) |
Chief Executive Officer (CEO) |
Invoke Capital (Myke Lynch) |
United Kingdom (GB) |
| Lüneborg, Nanna (Novo 201512 Investment Director at Novo Seeds) |
Investment Manager |
Novo Group (Group) |
Denmark |
| Lüninghöner, Karl-Heinz (Biofrontera 201202 Sales Manager) |
Sales Manager / Marketing Manager |
Biofrontera (Group) |
Germany |
| Lyons, Shane (Danaher 201709 President of Phenomenex) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United States (USA) |
| Lysikatos, Andrew (Axxin 201509 CEO) |
Chief Executive Officer (CEO) |
Axxin Pty Ltd. |
Australia |
| Lüth, Peter (Prophyta GmbH 201301 Managing Director + Co-founder) |
Managing Director |
Bayer (Group) |
Germany |
| Lüthgens, Kai-Jürgen (Cenata GmbH 201510 Managing Director) |
Managing Director |
Cenata GmbH |
Germany |
| Lütjens, Robert (Addex 201802 Head of Discovery) |
management (personnel) |
Addex (Group) |
Switzerland |
| Lütjohann, Dominic (Cubuslabs 201506– Mananaging Director + Co-Founder) |
Managing Director |
Labforward (Group) |
Germany |
| Lützeler, Claudia (Lützeler und Partner 200809 Dusseldorf) |
n. a. |
Lützeler und Partner Rechtsanwälte (Dusseldorf) |
Germany |
| Lämmerhofer, Michael (Univ Tübingen 201504 Professor) |
Professor |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
| Läubli, Markus (Metrohm 201411 Manager Marketing Support IC) |
Support Manager / Service Manager |
Metrohm (Group) |
Switzerland |
| Läufer, Albrecht (Direvo 201106– VP Unit Lignocellulose + Corvay Managing Director + BioRegioN Cluster Manager) |
Managing Director |
Direvo Industrial Biotechnology (Group) |
Germany |
| Löffert, Dirk (Qiagen 200604 Director RnD Nucleic Acid Modification + Amplification) |
Research & Development Manager |
Qiagen (Group) |
Germany |
| Löffler, M. (Uni Leipzig Institute for Medical Informatics 200606 Prof) |
Professor |
University of Leipzig |
Germany |
| Löffler, Markus |
n. a. |
University of Leipzig |
Germany |
| Löscher, Ralf (LECO 201106 Managing Director of LECO Instrumente GmbH) |
Managing Director |
Leco (Group) |
Germany |
| Löschmann, Peter-Andreas (Pfizer 201502) |
n. a. |
Pfizer (Group) |
Germany |
| Löwe, Robert Peter Stephan (GeneWake GmbH 200910– Managing Director) |
Managing Director |
R-Biopharm (Group) |
Germany |
| Maas, Cornelus (SHS 201812 Senior Investment Manager) |
Investment Manager |
SHS Gesellschaft für Beteiligungsmanagement mbH |
Germany |
| Maas, Jochen (Sanofi 201505 Managing Director RnD at Sanofi Germany) |
Research & Development Manager |
Sanofi (Group) [since May 2011] |
Germany |
| Maas, Ruth (Autodisplay Biotech GmbH 201112 Managing Director) |
Managing Director |
Autodisplay Biotech GmbH |
Germany |
| Maas, Werner (Bruker 201104 President Bruker BioSpin) |
President/Director/Head Business Group/Unit/Division |
Bruker Corporation (Group) |
Germany |
| Maaß, Peter (Univ Bremen 200901 Prof Zentrum für Technomathematik + SCiLS GmbH Co-Founder) |
Professor |
University of Bremen |
Germany |
| Maaß, Sebastian (Sopat GmbH 201302 Managing Director) |
Managing Director |
Iann (Group) |
Germany |
| MacCoss, Michael (Univ Washington 201209 Associate Professor + Head of MacCoss Lab of Biological Mass Spectrometry) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Washington |
United States (USA) |
| MacDougall, Douglas (MacDougall Biomedical Communications 201412 President + Founder) |
President/Director/Head Business Group/Unit/Division |
MacDougall Biomedical Communications Inc. (MBI) |
United States (USA) |
| Machnig, Matthias (Germany (govt) 201504 State Secretary at BMWi) |
Governmental Officer (personnel) |
Germany (govt) |
Germany |
| Macht, Marcus (AB Sciex 201407– Senior Proteomics Customer Support Manager EMEA before Bruker) |
Support Manager / Service Manager |
Danaher (Group) |
Germany |
| Macht, Martina (Bruker 201801 Head Commercial Back Office EMA at Bruker Daltonics) |
n. a. |
Bruker Corporation (Group) |
Germany |
| Mack, Matthias (Univ Regensburg 201207 Professor at University Hospital Regensburg Internal Medicine II) |
Professor |
University of Regensburg |
Germany |
| Mack, Mike (Syngenta – 201510 CEO before COO STEPPED DOWN 10/15) |
Chief Executive Officer (CEO) |
Syngenta (Group) |
Switzerland |
| MacKay, Charles (Pfizer 201509 CSO Inflammation + Immunology) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Pfizer (Group) |
United States (USA) |
| MacKay, Gerry (Sartorius 201703– EVP Marketing + Sales + Services Lab Division joined 2015 as CEO of BioOutsource) |
Chief Commercial Officer (CCO) |
Sartorius (Group) |
Germany |
| MacLaughlin, Fiona (ABP (NL) 201902 at Inkef Capital) |
Investment Manager |
ABP (Stichting Pensioenfonds) (Group) |
Netherlands |
| MacMartin-Moglia, Kim (Inova Diagnostics 201608 Director Business Development) |
Business Development Manager / Strategy Manager |
Werfen (Group) |
United States (USA) |
| Macoun, Roman (Thermo Fisher 201410) |
Sales Manager / Marketing Manager |
Thermo Fisher (Group) |
Germany |
| Madaus, Martin D. (JnJ 201507 CEO of Ortho Clinical Diagnostics before Quanterix + Millipore + Roche Dx North America) |
Board member |
Johnson & Johnson (JnJ) (Group) |
United States (USA) |
| Madigan, Sanford J. (Ankasa Regenerative 201507 CEO) |
Chief Executive Officer (CEO) |
Ankasa Regenerative Therapeutics Inc. |
United States (USA) |
| Madisch, Iljad (ResearchGATE 201705 Founder) |
Company Founder |
ResearchGate (Group) |
Germany |
| Madla, Raik (Arivis 201101 Managing Director) |
Managing Director |
Arivis – Multiple Image Tools GmbH |
Germany |
| Maelicke, Alfred (Galantos 201309 Managing Director + Founder of Galantos Pharma) |
Managing Director |
Galantos (Group) |
Germany |
| Maertens, Barbara (Cube Biotech 201212 Managing Director before Qiagen) |
Managing Director |
Cube Biotech GmbH |
Germany |
| Maertens, Geert (Biocartis 201310 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Biocartis (Group) |
Belgium |
| Magadeev, July (Delrus 201205 President) |
President/Director/Head Business Group/Unit/Division |
Delrus Inc. (RU) |
Russian Federation |
| Maggos, Chris (LifeSci Advisors 201511 Managing Director Europe before Addex 201106–201302 BusDev + Communication) |
Public Relations Manager / Investor Relations Manager |
LifeSci (Group) |
United States (USA) |
| Magni, Guido (Versant Ventures 201404 Venture Partner in Basel) |
Venture Partner |
Versant Ventures |
Switzerland |
| Mahadevia, Ankit (Atlas Venture 201306 Venture Partner) |
Partner (venture partner) |
Atlas Venture (Group) |
United States (USA) |
| Mahaffy, Patrick J. (Clovis Oncology 200904– CEO before Pharmion CEO) |
Chief Executive Officer (CEO) |
Clovis Oncology (Group) |
United States (USA) |
| Mahdavi, Behzad (Lonza 201704 VP Strategic Innovation + Alliances at Lonza Pharma&Biotech) |
Business Development Manager / Strategy Manager |
Lonza Group (Group) |
Switzerland |
| Mahieux, Patrick (Mérieux 201803 General Manager of ABL Europe) |
General Manager (management) |
Mérieux (Group) |
France |
| Mahler, Michael (Inova Diagnostics 201608 VP RnD) |
Research & Development Manager |
Werfen (Group) |
United States (USA) |
| Maier, Hans (Bayer 200801 Head Global Business Unit Diagnostic Imaging Bayer Schering Pharma) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Maier, Thomas (Wacker Biotech 200511) |
Managing Director |
Wacker (Group) |
Germany |
| Main, Alan (Sanofi 201610– EVP Consumer Healthcare before Bayer President HealthCare Medical Care business) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Maiore, Alain |
n. a. |
Evotec (Group) |
Germany |
| Mairhofer, Jürgen (enGenes Biotech GmbH 201509 Managing Director) |
Chief Executive Officer (CEO) |
EnGenes Biotech GmbH |
Austria |
| Maizi, Dina (Omnicom 201803 OMD Düsseldorf GmbH) |
n. a. |
Omnicom (Group) |
Germany |
| Makarov, Alexander A. (Thermo Fisher 200607– Director Global Research LS Mass Spec before Masslab Ltd + HD Technologies) |
Research & Development Manager |
Thermo Fisher (Group) |
Germany |
| Makhijani, Vinod (Roche 201506 VP + Project Leader at Roche Sequencing Business Development) |
Business Development Manager / Strategy Manager |
Roche (Group) |
Switzerland |
| Malcolm, Alastair (Applied Microarrays 200705 founder before GE Healthcare before Amersham before Motorola) |
Company Founder |
Applied Microarrays Inc. (AMI) |
United States (USA) |
| Maleck, Klaus (B Braun 201302– CEO TETEC AG before Evotec 201008– Corp Developm before Exec VP Financing + BioGeneriX) |
Chief Executive Officer (CEO) |
B. Braun (Group) |
Germany |
| Malfent, Lucia (MC Services 201211 before Intercell VP Global Head Corporate Communications) |
public relations / investor relations |
MC Services AG |
Germany |
| Malgouyres, Pascale (Poxel 200904– Business Development Director) |
Business Development Manager / Strategy Manager |
Poxel S.A. (Euronext: POXEL) |
France |
| Malier, Vanessa (Kurma 201412 Partner) |
Partner (venture partner) |
Kurma (Group) |
France |
| Malik, Arif (Microdiscovery 200501 Managing Director + Co-Founder) |
Managing Director |
MicroDiscovery GmbH |
Germany |
| Malik, Kemal (Bayer 201402– Executive Board Member for Innovation joined Bayer 1995 before BMS UK) |
Board member, executive |
Bayer (Group) |
Germany |
| Malik, Rajesh (Raj) (G1 Therapeutics 201406– CMO before Agennix + Adherex Technologies + EMD Pharmaceuticals+ BMS) |
Chief Medical Officer (CMO) |
HOPP Group (family of Dietmar Hopp) |
Germany |
| Malik, Shahzad (Adevent Venture Partners 201402 General Partner) |
General Partner (venture partner) |
Advent Venture Partners (Advent Ltd.) |
United Kingdom (GB) |
| Malin, Reinhard (Boehringer Ingelheim 201505 Director Media + PR) |
Public Relations Manager / Investor Relations Manager |
Boehringer Ingelheim (Group) |
Germany |
| Malkomes, Axel-Sven (Medigene 201904 – CFO + Chief BusDev Officer before Barclays + Société Générale + 3i + Merck KGaA) |
Chief Financial Officer (CFO) |
Medigene (Group) |
Germany |
| Malm, Anders (Manipal 201403– Managing Director of Ecron Acunova GmbH before Ecron Acunova A/S) |
Managing Director |
Manipal (Group) |
Germany |
| Malmström, Johan (Biognosys 200809– CSO + co-founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Biognosys AG |
Switzerland |
| Man, Anthony (Basilea Pharmaceutica –201212 CEO RESIGNED 12/12) |
Chief Executive Officer (CEO) |
Basilea (Group) |
Switzerland |
| Manchester, Keith (QVT 201705 Managing Director + Head Life Sciences QVT Financial LP) |
Investment Manager |
QVT (Group) |
United States (USA) |
| Mandelkern, Dave (Maverix Biomics 201306 CEO) |
Chief Executive Officer (CEO) |
Maverix Biomics Inc. |
United States (USA) |
| Mander, Thomas (Tom) (Domainex 201504– COO before Charles River + Asterand + Tripos UK + Evotec before GW + Xenova) |
Chief Operating Officer (COO) |
Domainex Ltd. |
United Kingdom (GB) |
| Mang, Manuel (M2. Technology & Project Consulting 201201 Managing Director) |
Managing Director |
M2. Technology & Project Consulting UG (haftungsbeschränkt) |
Germany |
| Mangasarian, Aram (Noxxon 201005 CBO before Novexel since 200511 VP BusDev before ExonHit VP BusDev) |
Chief Business Officer (CBO) |
Noxxon Pharma AG |
Germany |
| Mangelschots, Iris (Bruker Corp 201612 President of Bruker BioSpin Appplied, Industrial + Clinical division) |
President/Director/Head Business Group/Unit/Division |
Bruker Corporation (Group) |
Germany |
| Mangeolle, Jean-Paul (Danaher –201709 President of Sciex before Millipore RETIRED 9/17) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United States (USA) |
| Manieri, John (Cosmo 201707– Head of IR + Head of Investment Committee before Bellevue Asset Management) |
Public Relations Manager / Investor Relations Manager |
Cosmo Pharmaceuticals (Group) |
Ireland, Republic of |
| Mann, Erica L. (Bayer 201103– Head Bayer HealthCare Consumer Care Div before General Manager Pfizer Nutritional Health) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
|
| Mann, Jessica (Roche 201008 Head Translational Medicine before Evolva before Speedel before Roche before Novartis) |
Chief Medical Officer (CMO) |
Roche (Group) |
Switzerland |
| Mann, Matthias (Max Planck 200808 MPI for Biochemistry) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
| Mann, William (Helsinn 201705 CEO of Helsinn Therapeutics (U.S.) Inc) |
Chief Executive Officer (CEO) |
Helsinn (Group) |
United States (USA) |
| Mann, Wolfgang (Olympus before Advalytix AG before Alopex GmbH Managing Director) |
n. a. |
Danaher (Group) |
Germany |
| Mannhardt, Boris (Biocom Projektmanagement GmbH 200710 Managing Director + Apanovis before IBG Sachsen-Anhalt + Bio-M) |
Managing Director |
Biocom (Group) |
Germany |
| Manninga, Heiko (Neuway Pharma GmbH 201504 Managing Director) |
Managing Director |
Neuway Pharma GmbH |
Germany |
| Manore, Hadar (Paragon Conventions 201304 Project Manager – Industry Liaison) |
Event Manager / Conference Manager |
Paragon (IL) (Group) |
Switzerland |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 35 36 37 ... 65 66 67 
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lsus-life-sciences-usa-com-beta.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
